2016 International Congress Archives - Page 12 of 207

12:30pm-2:00pm: Cognitive profile in the Parkinsonian variant of multiple system atrophy: Findings from a Tunisian cohort

A. Nasri, M. Ben Djebara, I. Kacem, Y. Sidhom, A. Gargouri, R. Gouider (Tunis, Tunisia)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus) · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Comorbid conditions associated with Parkinson´s disease: A longitudinal study

D. Santos García, E. Suarez Castro, I. Expósito, T. de Deus, C. Tuñas, D. Núñez Arias, Á. Aneiros, M. López Fernández, J. Naveiro, J. Abella, M.A. Llaneza, V. Vilas, M. Macías (Ferrol, Spain)

Epidemiology · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Comorbidity and Parkinson’s disease phenotype, dopaminergic function and CSF biomarkers

T. Yousaf, G. Pagano, F. Niccolini, M. Politis (London, United Kingdom)

Parkinson's disease: Non-motor symptoms · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Comparative analysis of freezing of gait in distinct parkinsonism types by diffusion tensor imagining and cognitive profiles

H. Onder, E.S. Topcuoglu, A.C. Has, K.K. Oguz, B. Elibol (Ankara, Turkey)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus) · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Comparative gait analysis of patients with vascular parkinsonism and idiopathic Parkinson’s disease

B. Mondal, S. Choudhury, M.U. Kulsum, P. Chatterjee, S. Chatterjee, K. Chatterjee, R. Banerjee, S.S. Jha, S.S. Anand, H. Kumar (Kolkata, India)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus) · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Comparing psychosocial risk factors in patients with functional movement disorders and patients with psychogenic non-epileptic seizures

C.W. Maurer, G.M. Capitan, G. Limachia, K. LaFaver, E. Considine, A. Curran, W.C. LaFrance, M. Hallett (Bethesda, MD, USA)

Epidemiology · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Comparing the characteristics of patients with Parkinson’s disease speech with and without deep brain stimulation

M.R. Olchik, A.L. Bressanelli, M. Presotto, A.F.S. Schuh, C.R.M. Rieder (Porto Alegre, Brazil)

Surgical therapy: Parkinson's disease · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Comparison of clinically derived and model based programming parameters of subthalamic nucleus stimulation in Parkinson’s disease

R. Reese, M.M. Reich, R. Nilunsing, W. Pollet, J. Volkmann (Würzburg, Germany)

Surgical therapy: Parkinson's disease · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Comparison of cognitive and neuropsychological manifestations in patients with progressive supranuclear palsy (Psp) and Parkinson’s disease

M.U. Kulsum, S.S. Anand, S. Chatterjee, P. Chatterjee, B. Mondal, S. Choudhury, K. Chatterjee, R. Banerjee, S.S. Jha, H. Kumar (Kolkata, India)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus) · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Comparison of effect of variable deep brain stimulation (DBS) frequencies on gait and balance in Parkinson’s disease (PD) patients with either bilateral GPi or STN stimulators employing wearable wireless sensors

A. Deep, A. Lieberman, R. Dhall, T. Lockhart, C. Frames, S. Shafer, N. Tateuchi, E. Simpson, M. McCauley, N. Krishnamurthi (Phoenix, AZ, USA)

Surgical therapy: Parkinson's disease · Exhibit Hall located in Hall B, Level 2